Tech Company Financing Transactions
Claris Bio Funding Round
Claris Bio secured a $57 million funding round on 1/8/2024. Investors included Janus Henderson Investors, Mass General Brigham Ventures and Novo Holdings.
Transaction Overview
Company Name
Announced On
1/8/2024
Transaction Type
Venture Equity
Amount
$57,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
299 Pavonia Avenue 3-8
Jersey City, NJ 07302
USA
Jersey City, NJ 07302
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Claris is pioneering solutions for patient populations struggling with sight-threatening corneal diseases. Claris Biotherapeutics, licensing intellectual property from Massachusetts Eye and Ear Infirmary (MEEI) and accessing drug substance in an agreement with partner Kringle Pharma.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clarke Atwell
Chief Medical Officer
Susan Orr
VP - Bus. Development
Henry Rath
Browse more venture capital transactions:
Prev: 1/8/2024: UpDoc venture capital transaction
Next: 1/8/2024: CharacterX venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs